St. Clair Advisors, LLC Abb Vie Inc. Transaction History

St. Clair Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Apr 10, 2025	BUY	$138.31 - $165.87 $339,136 - $406,713	2,452 Added 93.55%	5,073 $820 Million
Q2 2022 Apr 10, 2025	SELL	$137.62 - $174.96 $54,772 - $69,634	-398 Reduced 13.18%	2,621 $401 Million
Q4 2021 Apr 10, 2025	BUY	$107.43 - $135.93 $324,331 - $410,372	3,019 New	3,019 $409 Million
Q3 2021 Apr 10, 2025	BUY	$106.4 - $120.78 $34,260 - $38,891	322 Added 10.67%	3,341 $360 Million
Q4 2020 Apr 10, 2025	BUY	$80.49 - $108.67 $242,999 - $328,074	3,019 New	3,019 $323 Million

4,489

1.28B

16.9M

15.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $414B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of St. Clair Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on St. Clair Advisors, LLC with notifications on news.